Tonix Pharmaceuticals Holding Corp.

( )
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.04%53.990.9%$1408.53m
JNJJohnson & Johnson -0.19%179.200.7%$1293.99m
BMYBristol-Myers Squibb Co. 0.01%77.601.0%$1212.32m
MRKMerck & Co., Inc. -0.02%92.300.7%$1166.77m
ABBVAbbVie, Inc. 0.05%150.631.9%$1100.81m
LLYEli Lilly & Co. 0.22%314.161.1%$969.38m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%142.980.0%$491.89m
AZNAstraZeneca Plc -0.05%66.671.0%$491.28m
NVSNovartis AG 0.19%91.430.2%$260.33m
GSKGlaxoSmithKline Plc -0.26%44.300.2%$256.90m
VERUVeru, Inc. -0.16%12.620.0%$253.31m
HZNPHorizon Therapeutics Plc 0.00%90.595.4%$196.03m
SGENSeagen Inc. 0.46%139.105.7%$186.52m
NVONovo Nordisk A/S -0.58%106.000.1%$181.83m
VTRSViatris, Inc. 0.58%12.080.0%$166.23m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.